Revolutionizing VR: How Arm Patents And Ultrasound Technology Can Minimize Motion Sickness
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Before you orderOffer from Amazon

Get the latest gadgets delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

Arm has been granted a patent for a head-mounted device that uses ultrasound to stimulate the vestibular system, aiming to reduce VR motion sickness. The technology could enable more comfortable extended reality experiences.

Arm, a subsidiary of SoftBank, has been granted a patent for a head-mounted system designed to reduce motion sickness in virtual reality (VR) and extended reality (XR) devices. The patent describes a method that analyzes visual motion in the displayed images and sends control signals to ultrasonic transducers to stimulate the wearer’s vestibular system, potentially aligning perceived movement with visual cues. This development could significantly improve comfort and usability for VR users, especially during prolonged sessions.

The patent, titled “Method for minimising motion sickness for head-mountable extended reality,” was filed in the US on July 24, 2023, and granted on June 16, 2026. It details a head-mounted device that compares visual motion against a threshold and, when necessary, activates ultrasonic transducers to stimulate the inner ear’s vestibular system. The goal is to counteract the sensory mismatch that often causes dizziness, nausea, and discomfort during VR use.

The system leverages low-intensity focused ultrasound (LiFU) and ultrasonic transducers, which can be arranged in arrays targeting each ear. These arrays may use beamforming techniques to precisely stimulate specific parts of the inner ear, thereby providing physical cues that match visual motion. The patent also suggests alternative responses, such as reducing visual motion, fading images, or adjusting the displayed content to improve comfort. It emphasizes an adaptive approach, dynamically recalibrating based on the user’s pose, motion, and preferences, and based on sensor data indicating misalignment between visual and physical sensations.

While the patent details a promising approach, it remains unclear whether this ultrasonic vestibular stimulation system will be integrated into commercial XR headsets. The technology is still in the conceptual and patent stage, with no confirmed plans for product development or deployment at this time.

At a glance
reportWhen: announced June 16, 2026
The developmentArm’s new patent details a system that applies ultrasonic stimulation to the inner ear to minimize VR motion sickness by aligning physical and visual cues.

Potential Impact on VR User Comfort

This patent signals a possible breakthrough in addressing one of the most persistent barriers to widespread VR adoption: motion sickness. By directly stimulating the vestibular system to match visual cues, this technology could enable longer, more comfortable VR sessions, expanding its use in gaming, training, and professional applications. If successfully developed, it might set a new standard for user experience in XR devices, reducing the need for software-based motion smoothing or visual adjustments alone.

Amazon

VR motion sickness reduction devices

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Background on Vestibular Stimulation in VR

Motion sickness has long been a challenge in VR, caused by a mismatch between visual motion and the inner ear’s sense of balance. Various approaches have been explored, including software solutions like reducing motion speed or adding vignettes, but none have fully eliminated discomfort. Vestibular stimulation, which involves physically influencing the balance system, has been proposed as a more direct solution. Prior research has considered electrical stimulation methods, but no commercial VR device has yet incorporated such techniques.

Arm’s recent patent indicates a shift toward integrating physical sensory feedback with visual content, leveraging ultrasound technology. While ultrasound has been used in medical applications for precise tissue stimulation, its application in VR for vestibular control remains experimental and unproven at a commercial scale.

“The use of ultrasonic stimulation to align the vestibular system with visual cues could revolutionize comfort in extended VR use.”

— an anonymous researcher

Unanswered Questions About Practical Implementation

It is not yet clear whether ultrasonic vestibular stimulation can be delivered with sufficient precision and comfort in real-world VR headsets. The effectiveness across diverse users, the safety of prolonged stimulation, and integration with existing hardware remain untested. Additionally, regulatory approval and user acceptance are still unknowns.

Next Steps Toward Commercial VR Integration

Further research and development are needed to validate the technology’s safety and efficacy. Industry players may conduct prototype testing, user trials, and safety assessments in the coming months. If successful, we could see early experimental devices or partnerships aiming to incorporate ultrasonic vestibular stimulation into next-generation VR headsets within the next few years.

Key Questions

Could this ultrasonic system completely eliminate VR motion sickness?

While it has the potential to significantly reduce discomfort, it is too early to say whether it can fully eliminate motion sickness. Further testing is needed to determine its effectiveness across different users and scenarios.

Is this technology safe for prolonged use?

The safety of long-term ultrasonic vestibular stimulation has not yet been established. Regulatory approval and comprehensive safety studies will be required before commercial deployment.

When might we see this technology in consumer VR headsets?

If development progresses successfully, prototypes could emerge within the next few years, with potential commercial products several years away, depending on testing and regulatory processes.

Will this require new hardware components in VR headsets?

Yes, integrating ultrasonic transducers and related control systems would likely necessitate hardware modifications, increasing complexity and cost.

Could this technology be used for other applications besides VR?

Potentially, yes. Precise vestibular stimulation could have applications in medical treatments, balance therapy, or other immersive experiences requiring physical feedback.

Source: Road to VR

COLUMBUS DAY / I

Columbus Day / Indigenous Peoples' Day Picks

As an affiliate, we earn on qualifying purchases.

You May Also Like

Robot Vacuums: LiDAR vs Camera Navigation (Pick the Right One)

Great choices in robot vacuum navigation depend on your needs, but discover which system offers the best performance and reliability for your home.

OLED vs Mini‑LED vs QLED: What You’re Actually Paying For

An in-depth look at OLED, Mini‑LED, and QLED reveals the key differences, helping you understand what you’re actually paying for and which is right for you.

What A Benchmark Partner Sees That The Zero-Sum Crowd Misses

Eric Vishria of Benchmark warns against fixed-pie assumptions in AI, emphasizing a growing ecosystem of multiple winners across layers.

Wi‑Fi 6E Vs Wi‑Fi 7: What Changes in Real Life

Just how will Wi‑Fi 6E and Wi‑Fi 7 transform your daily connectivity—and what do you really need to know?